SCI:NYSEService Corporation International Analysis
Data as of 2026-06-21 - not real-time
$72.62
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Service Corporation International is trading at $72.62, which sits below its 20‑day ($73.65), 50‑day ($78.20) and 200‑day ($79.88) simple moving averages, indicating a short‑term bearish bias. However, the MACD histogram has turned positive (0.35) and the MACD signal is deemed bullish, while the RSI at 42.9 suggests the stock is not yet oversold. The price is hovering just above a key support level of $68.41 and has a resistance ceiling near $78.04, with volume trending upward, hinting at a potential technical bounce.
Fundamentally, SCI delivers solid profitability (operating margin 22.1%, profit margin 12.4%) and an impressive ROE of 33%, but its balance sheet is heavily leveraged (debt‑to‑equity 326%) and the DCF‑derived fair value of roughly $3.05 starkly contrasts with the current market price, flagging a significant overvaluation signal. The dividend yield of 1.98% with a payout ratio of 35% appears sustainable given strong cash flow, yet the high debt burden could pressure future payouts. Recent corporate news – a $472 million increase to the share‑repurchase program that lifted the stock 4.1% intraday – provides a short‑term catalyst, while analyst consensus targets around $96–$97 suggest upside potential if valuation concerns are mitigated.
Fundamentally, SCI delivers solid profitability (operating margin 22.1%, profit margin 12.4%) and an impressive ROE of 33%, but its balance sheet is heavily leveraged (debt‑to‑equity 326%) and the DCF‑derived fair value of roughly $3.05 starkly contrasts with the current market price, flagging a significant overvaluation signal. The dividend yield of 1.98% with a payout ratio of 35% appears sustainable given strong cash flow, yet the high debt burden could pressure future payouts. Recent corporate news – a $472 million increase to the share‑repurchase program that lifted the stock 4.1% intraday – provides a short‑term catalyst, while analyst consensus targets around $96–$97 suggest upside potential if valuation concerns are mitigated.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Technical bounce potential at support
- Positive MACD divergence
- Recent $472 M share‑repurchase authorization
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage (debt‑to‑equity >300%)
- Valuation gap between price and DCF fair value
- Stable dividend and strong cash flow
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Demographic tailwinds for death‑care services
- Persistent balance‑sheet risk from debt load
- Analyst price targets indicating upside if debt is managed
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin12.36%
P/E Ratio19.2
ROE33.11%
ROA3.40%
Debt/Equity325.74
P/B Ratio6.3
Op. Cash Flow$965.4M
Free Cash Flow$369.4M
Technical Analysis
TrendBearish
RSI42.9
Support$68.41
Resistance$78.04
MA 20$73.65
MA 50$78.20
MA 200$79.88
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$3.05
Target Price$96.33
Upside/Downside32.65%
GradeOvervalued
TypeBlend
Dividend Yield1.98%
Risk Assessment
Beta0.03
Volatility28.58%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.